Literature DB >> 19411802

Ghrelin response to oral glucose load in hyperthyroidism, before and after treatment with antithyroid drugs.

A Theodoropoulou1, A Psyrogiannis, I C Metallinos, I Habeos, A G Vgenakis, V Kyriazopoulou.   

Abstract

Hyperthyroidism is characterized by hyperphagia and increased basal metabolic rate. Ghrelin peptide is implicated in food intake through activation of the orexigenic neuropeptide Y/agouti related protein in the arcuate nucleus of hypothalamus. Also different studies suggested that ghrelin might play a role in states of energy insufficiency, controlling body weight. We therefore evaluate ghrelin levels in severe hyperthyroidism before and after medical treatment when euthyroidism was achieved, in order to evaluate its possible role in the increase of appetite and in the metabolic changes observed in hyperthyroidism. Serum ghrelin and insulin levels were measured after an oral glucose tolerance test (OGTT), in 7 severe hyperthyroid female patients, before and after medical treatment when euthyroidism was achieved. Body mass index (BMI), percentage of body fat and lean mass was also estimated in hyperthyroidism as well as in euthyroidism. Basal insulin levels were statistically higher in hyperthyroid patients with respect to euthyroid state after treatment (p=0.02, t=3.379), while homeostasis model assessment (HOMA) index for insulin sensitivity was statistically higher in hyperthyroidism (group 1) compared to euthyroidism (group 2) (1.64+/-0.69 vs 0.78+/-0.44, p=0.019, t=3.389). Fasting ghrelin concentrations were significantly reduced in group 1 compared to group 2 (938+/-578 pg/ml vs 1402+/-566 pg/ml, p<0.05, t=-2.489). Oral glucose loading induced suppression of ghrelin level in both groups, but the area under the curve for ghrelin during the OGTT in euthyroidism was greater compared to hyperthyroidism (p=0.05, t=-2.485). After medical treatment, a statistically significant increase in BMI (23.1+/-4.3 vs 25.9+/-5.1) (p=0.007, t=-4.399) was also observed. In hyperthyroidism, basal ghrelin levels showed a negative correlation with BMI (p=0.042, r=-0.829), insulin (p<0.001, r=-1.000), and HOMA index (p=0.019, r=-0.886). No correlation was found between ghrelin levels and thyroid hormone values. Ghrelin levels are decreased in hyperthyroidism and increase when euthyroidism is achieved. BMI and insulin are the main factors that influence ghrelin concentration in hyperthyroidism. T3 and T4 levels do not influence ghrelin levels. There is no evidence that ghrelin is responsible for the increase appetite seen in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411802     DOI: 10.1007/BF03345693

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Diabetes, obesity, and the brain.

Authors:  Michael W Schwartz; Daniel Porte
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Influence of gastric emptying-rate and of insulin response on oral glucose tolerance in thyroid disease.

Authors:  C D Holdsworth; G M Besser
Journal:  Lancet       Date:  1968-09-28       Impact factor: 79.321

4.  Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels.

Authors:  J W Doar; T C Stamp; V Wynn; T K Audhya
Journal:  Diabetes       Date:  1969-09       Impact factor: 9.461

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

6.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Authors:  Tomomi Shiiya; Masamitsu Nakazato; Masanari Mizuta; Yukari Date; Muhtashan S Mondal; Muneki Tanaka; Shin-Ichi Nozoe; Hiroshi Hosoda; Kenji Kangawa; Shigeru Matsukura
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

9.  Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

Authors:  Seppo M Pöykkö; Eija Kellokoski; Sohvi Hörkkö; Heikki Kauma; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

Review 10.  The role of thyroid hormones in the control of energy expenditure.

Authors:  E Danforth; A Burger
Journal:  Clin Endocrinol Metab       Date:  1984-11
View more
  3 in total

1.  Glucose metabolism before and after radioiodine therapy of a patient with Graves' disease: Assessment by continuous glucose monitoring.

Authors:  Yun Hu; Gu Gao; Reng-Na Yan; Feng-Fei Li; Xiao-Fei Su; Jian-Hua Ma
Journal:  Biomed Rep       Date:  2017-06-21

2.  Ghrelin and leptin secretion in patients with moderate Alzheimer's disease.

Authors:  A Theodoropoulou; I C Metallinos; A Psyrogiannis; G A Vagenakis; V Kyriazopoulou
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

3.  Thyroid disorders and diabetes mellitus.

Authors:  Mirella Hage; Mira S Zantout; Sami T Azar
Journal:  J Thyroid Res       Date:  2011-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.